Hyperoncotic human albumin solutions for intravenous fluid therapy: Effectiveness of pathogen safety and purification methods, and clinical safety

Albumin solutions derived from human plasma have demonstrated clinical benefits as intravenous fluid therapy in clinical settings such as liver disease, sepsis, intensive care, and surgery. For all plasma-derived medicinal products, there is a potential risk from pathogens, including relevant blood-...

Full description

Bibliographic Details

Published in:	Biosafety and Health
Main Authors:	Toby Simon, Philipp Schumann, Michael Bieri, Kathrin Schirner, Eleonora Widmer
Format:	Article
Language:	English
Published:	Elsevier 2023-02-01
Subjects:	Hyperoncotic albumin Human albumin solutions Viral reduction Pathogen safety Pasteurization Plasma-derived medicinal product
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590053622001793